Steven Valliere

Director, Neurology Medical Science Liaisons, Regional Team Lead - East at Sunovion Pharmaceuticals - Marlborough, Massachusetts, US

Steven Valliere's Colleagues at Sunovion Pharmaceuticals
Dianel McLoughlin

Associate Director, Worldwide Strategic Marketing

Contact Dianel McLoughlin

Brian Wensel

Director of Health Economics and Outcomes Research

Contact Brian Wensel

Pamela Alsbrooks

Associate Director Regional Marketing Liaison

Contact Pamela Alsbrooks

Scott Brown

Director, Computational Chemistry

Contact Scott Brown

Sanjay Sharma

Director of Medical Affairs

Contact Sanjay Sharma

Estela Skende

Associate Director, Bioanalytical Sciences

Contact Estela Skende

Barbara Spada

Sr. Director Market Access Strategy

Contact Barbara Spada

View All Steven Valliere's Colleagues
Steven Valliere's Contact Details
HQ
(508) 481-6700
Location
Company
Sunovion Pharmaceuticals
Steven Valliere's Company Details
Sunovion Pharmaceuticals logo, Sunovion Pharmaceuticals contact details

Sunovion Pharmaceuticals

Marlborough, Massachusetts, US • 1042 Employees
Major Drugs

This page is no longer active or monitored. We are now Sumitomo Pharma America (SMPA), a science-based, technology-driven biopharmaceutical company focused on delivering therapeutic and scientific breakthroughs in areas of critical patient need. See pinned post for our new page and follow us!⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀ ==== Sunovion is a global biopharmaceutical company focused on the innovative application of science and medicine to help people with serious medical conditions. Sunovion’s spirit of innovation is driven by the conviction that scientific excellence paired with meaningful advocacy and relevant education can improve lives. The Company has charted new paths to life-transforming treatments that reflect ongoing investments in research and development and an unwavering commitment to support people with serious neurological and psychiatric conditions. Sunovion’s track record of discovery, development and commercialization of important therapies has included Latuda® (lurasidone HCI), Aptiom® (eslicarbazepine acetate) Lonhala® Magnair® (glycopyrrolate), and, most recently, KYNMOBI® (apomorphine HCI) sublingual film. Headquartered in Marlborough, MA Sunovion is an indirect, wholly owned subsidiary of Sumitomo Pharma Co., Ltd. Sunovion Pharmaceuticals Canada, Inc., based in Mississauga, Ontario, is a wholly-owned direct subsidiary of Sunovion Pharmaceuticals Inc. Find more information at www.sunovion.com and connect on Twitter and Facebook @Sunovion. LATUDA is a registered trademark of Sumitomo Pharma Co., Ltd. APTIOM is used under license from BIAL. KYNMOBI is a registered trademark of Sunovion Pharmaceuticals Inc. LONHALA MAGNAIR is a registered trademarks of Sunovion Pharmaceuticals Inc. © 2023 Sunovion Pharmaceuticals Inc. To view our community guidelines, see here: bit.ly/3CozDLX

Neurological Care Pharmaceutical Research Psychiatric Treatments Biopharmaceuticals Medical Innovation Scientific Advancement Therapeutic Activities Drug Development And Manufacturing Clinical Trials Patient Advocacy
Details about Sunovion Pharmaceuticals
Frequently Asked Questions about Steven Valliere
Steven Valliere currently works for Sunovion Pharmaceuticals.
Steven Valliere's role at Sunovion Pharmaceuticals is Director, Neurology Medical Science Liaisons, Regional Team Lead - East.
Steven Valliere's email address is ***@sunovion.com. To view Steven Valliere's full email address, please signup to ConnectPlex.
Steven Valliere works in the Major Drugs industry.
Steven Valliere's colleagues at Sunovion Pharmaceuticals are Dianel McLoughlin, Brian Wensel, Pamela Alsbrooks, Scott Brown, Sanjay Sharma, Estela Skende, Barbara Spada and others.
Steven Valliere's phone number is (508) 481-6700
See more information about Steven Valliere